| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/18/2012 | CN102579317A Cantharidin vesicles and preparation thereof and preparation methods of cantharidin vesicles and preparation thereof |
| 07/18/2012 | CN102578508A Preparation method of Noni fruit purification and fermentation liquid |
| 07/18/2012 | CN102578030A Selenium-enriched ground beetle breeding method, capsules of freeze-dried powder of selenium-enriched ground beetles, protein hydrolysate of selenium-enriched ground beetles, and medicinal uses of selenium-enriched ground beetles |
| 07/18/2012 | CN102416083B Medicinal composition for treating esophagus cancer |
| 07/18/2012 | CN102198085B Triblock copolymer loaded taxane medicaments micelle and freeze-drying preparation, and preparation method and application thereof |
| 07/18/2012 | CN102198083B Micelles and freeze-dried preparations of diblock polymer-supported taxane medicines and preparation and use thereof |
| 07/18/2012 | CN102153529B Single-tetrahydrofuran-type annonaceous acetogenin compounds with antitumor activity and application thereof |
| 07/18/2012 | CN102114099B Traditional Chinese medicine preparation for inhibiting liver cancer and preparation method thereof |
| 07/18/2012 | CN102091046B Fludarabine phosphate freeze-dried powder injection and preparation method thereof |
| 07/18/2012 | CN102070725B Sulfated galactan, and preparation method and application thereof |
| 07/18/2012 | CN102060934B Enzymatic extraction method for auricularia auricula polysaccharides |
| 07/18/2012 | CN102041270B Construction and screening of siRNAs (small interfering RANs) expression vectors of gastric cancer targeted DEC1 (differentiated embryo-chondrocyte expressed gene 1) and application thereof |
| 07/18/2012 | CN102020651B 6-aryl amino pyridone formamide MEK (methyl ethyl ketone) inhibitor |
| 07/18/2012 | CN102008495B Application of berberine and doxorubicine mixed preparation in preparation of medicament against doxorubicine cardiac dysfunction or tumor |
| 07/18/2012 | CN102008439B Curcumin coated liposome preparation and preparation method thereof |
| 07/18/2012 | CN101991550B Norcantharidin tablet and preparation method thereof |
| 07/18/2012 | CN101987086B Ultra-fine bicalutamide oral tablet and preparation method thereof |
| 07/18/2012 | CN101973989B Thiazole amide compound and medicinal application thereof for treating malignancy |
| 07/18/2012 | CN101948429B 1-methyl-7H-indene[1, 2-b]quinolinetrifluoromesylate-7-(4-dimethylamino) benzyl alkene derivant and preparation thereof |
| 07/18/2012 | CN101880283B Azaindole kinase inhibitors |
| 07/18/2012 | CN101879144B Pirarubicin or pirarubicin hydrochloride liposome freeze-drying agent and preparation method thereof |
| 07/18/2012 | CN101875693B Albumin variant having anti-angiogenesis activity and preparation method thereof |
| 07/18/2012 | CN101863958B Induction of the mitochondrial permeability transition |
| 07/18/2012 | CN101863894B Tanshinone II A derivative and preparation method and application thereof |
| 07/18/2012 | CN101863887B Matrine derivative and preparation method thereof |
| 07/18/2012 | CN101863878B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 07/18/2012 | CN101863867B Derivatives of flavonoids compounds and preparation method and application thereof |
| 07/18/2012 | CN101854955B Mitochondria-targeted anti-tumor agents |
| 07/18/2012 | CN101851238B Substituted 8-heteroaryl xanthines |
| 07/18/2012 | CN101837091B Process for continuously extracting polygonatum saponin and polygonatum polysaccharose |
| 07/18/2012 | CN101831427B Oligodeoxyribonudeotide for preventing recurrence of tumor and inhibiting tumor growth as well as application thereof |
| 07/18/2012 | CN101817805B Andrographolide derivative and preparation method and application thereof |
| 07/18/2012 | CN101810593B Elemene sustained-release tablets |
| 07/18/2012 | CN101805390B Tripterine derivate and use thereof |
| 07/18/2012 | CN101736050B Preparation method of arctigenin |
| 07/18/2012 | CN101735310B Human papilloma virus (HPV) fusion protein, gene, carrier, strain, preparation method and application |
| 07/18/2012 | CN101720315B Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer |
| 07/18/2012 | CN101683322B Method for preparing nano berberine hydrochloride liposome by supercritical carbon dioxide method |
| 07/18/2012 | CN101678029B Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders |
| 07/18/2012 | CN101671382B Ultra-micronized megestrol acetate and pharmaceutical composition containing same |
| 07/18/2012 | CN101654485B Spreading hedvotis herb polysaccharide for curing malignant tumor and preparation method thereof |
| 07/18/2012 | CN101595115B Organo-arsenoxide compounds and use thereof |
| 07/18/2012 | CN101595098B 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 07/18/2012 | CN101590103B Traditional Chinese medicine combination for treating leukemia and preparation method thereof |
| 07/18/2012 | CN101549004B Effective components of seed of cowherb and preparation method thereof |
| 07/18/2012 | CN101524375B Wet-process wall breaking method of lucidum spore powder |
| 07/18/2012 | CN101516881B 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 07/18/2012 | CN101501038B Fused [d]pyridazin-7-ones |
| 07/18/2012 | CN101428063B Effective component of schisandra chinensis, preparation method and use thereof |
| 07/18/2012 | CN101407524B Oxazino camptothecin derivative, preparation and use thereof |
| 07/18/2012 | CN101328166B 2-dihydroindole ketone derivate as protein kinase inhibitor and histone deacetylase inhibitor |
| 07/18/2012 | CN101326175B Polymorphs of a C-MET/HGFR inhibitor |
| 07/18/2012 | CN101240022B Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 07/18/2012 | CN101234203B Novel medical photosensitive agent for anti-tumor treatment and preparation thereof |
| 07/18/2012 | CN101177425B Novel epothilones compound as well as preparation method and use thereof |
| 07/18/2012 | CN101137391B Uses of recombinant super-compound interferon |
| 07/18/2012 | CN101108872B Plants natural base extract and formulated product and use thereof |
| 07/18/2012 | CN101108224B Plants natural base extractive and formulated product and use thereof |
| 07/18/2012 | CN101072781B Macrocyclic quinazoline derivatives and their use as mtki |
| 07/18/2012 | CN101031339B Lysis/resealing process and device for incorporating an active ingredient in erythrocytes |
| 07/17/2012 | US8222405 Phenylalanine derivatives |
| 07/17/2012 | US8222394 MicroRNA molecules |
| 07/17/2012 | US8222393 Using U7 polypeptide as diagnostic and therapeutic tool preventing and treating cell proliferative disorders |
| 07/17/2012 | US8222392 Kit for detection of telomerase reverse transcriptase nucleic acids |
| 07/17/2012 | US8222277 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/17/2012 | US8222244 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 07/17/2012 | US8222231 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 07/17/2012 | US8222036 Oncolytic viruses as phenotyping agents for neoplasms |
| 07/17/2012 | US8222008 Methods and compositions for treating cancer |
| 07/17/2012 | US8221794 Anti-angiogenic nanoparticle compositions |
| 07/17/2012 | US8221790 Therapeutic polyesters and polyamides |
| 07/17/2012 | US8221779 Compositions and methods for the delivery of poorly water soluble drugs and methods of treatment |
| 07/17/2012 | US8221754 Antihuman α9 integrin antibody and use of the same |
| 07/17/2012 | US8221735 Embolic compositions |
| 07/17/2012 | CA2700319C Carbonates for use in the preparation of derivatives of dioxan-2-alkyl carbamates |
| 07/17/2012 | CA2674436C Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
| 07/17/2012 | CA2637658C Aurora kinase modulators and method of use |
| 07/17/2012 | CA2501089C 4-methylhexanoic kahalaide f compound |
| 07/17/2012 | CA2492964C Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 07/17/2012 | CA2492659C 6-(3-pyridyl-methylamino)purine derivatives and their use as antiproliferative agents |
| 07/17/2012 | CA2488373C N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris |
| 07/17/2012 | CA2488366C Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 07/17/2012 | CA2482002C Curcumin analogues and uses thereof |
| 07/17/2012 | CA2469187C Cis-2,4,5-triphenyl-imidazolines and their use in the treatment of tumors |
| 07/17/2012 | CA2468796C Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |
| 07/17/2012 | CA2446955C A device for forming or increasing the number of undifferentiated cells |
| 07/17/2012 | CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof |
| 07/17/2012 | CA2355976C Vascular endothelial cell growth factor antagonists and uses thereof |
| 07/17/2012 | CA2334342C Epothilone derivatives and their synthesis and use |
| 07/17/2012 | CA2266325C A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 07/12/2012 | WO2012094679A2 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors |
| 07/12/2012 | WO2012094653A2 Compositions and methods for macromolecular drug delivery |
| 07/12/2012 | WO2012094574A2 Stabilized polyribonucleotide nanoparticles |
| 07/12/2012 | WO2012094541A2 Acoustically responsive particles with decreased cavitation threshold |
| 07/12/2012 | WO2012094451A1 Novel ureas for the treatment and prevention of cancer |
| 07/12/2012 | WO2012094313A1 Pyrazole derivatives as erk inhibitors |
| 07/12/2012 | WO2012094252A1 Anti-hla-e antibodies, therapeutic immunomodulatory antibodies to human hla-e heavy chain, useful as ivig mimetics and methods of their use |
| 07/12/2012 | WO2012094033A1 Methods of making liposomes, liposome compositions made by the methods, and methods of using the same |
| 07/12/2012 | WO2012094010A1 Compositions and methods of aloe polysaccharides |
| 07/12/2012 | WO2012093920A2 Composition including white morning glory extract for treating leukemia |